Hearts expressing both CryABR120G and RNAi targeted against Zw (the gene encoding G6PD) exhibited significantly shorter heart periods (increased heart rates; Figure 1B), significantly reduced arrhythmia indices and systolic diameters, and significantly greater fractional shortening (Figure 1C–F). The gene discussed is G6PD; the disease is Arrhythmia.